SLS — SELLAS Life Sciences Group, Inc. stock price, charts and financials

QT66SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.81
+0.59+5.26%
OverviewShort InterestFilings
SLSQT66SELLAS Life Sciences Group, Inc.·NASDAQ
11.81+5.26%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 20268-KCurrent report
Jun 25, 20268-KCurrent report
Jun 18, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 16, 2026S-8Registration of employee benefit securities
Jun 02, 20268-KCurrent report
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
Apr 24, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 2026S-3ASRS-3ASR
Mar 19, 202610-KAnnual report
Mar 19, 20268-KCurrent report
Mar 11, 20268-KCurrent report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 09, 20264Statement of changes in beneficial ownership
Jan 09, 20264Statement of changes in beneficial ownership
Jan 09, 20264Statement of changes in beneficial ownership
Jan 09, 20264Statement of changes in beneficial ownership
Jan 09, 20264Statement of changes in beneficial ownership
#1 / 25 of 216
Page
▼
/ 9